(3aR,7aR)-Hexahydroisobenzofuran-1,3-dione, 98%, 1g

4-Chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, 98%, 1g

1-(4-Carboxyphenyl)-5-mercapto-1H-tetrazole>95.0%(HPLC)(T)5g

3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 97.0%, 1g

3'-Methoxy-2'-nitroacetophenone, 95.0%, 1g

4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid amide, 95.0%, 1g

Azocarmine G (CI 50085), pure, 10 g, glass packaging

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

2-Chloro-4-(trifluoromethyl)quinoline, 98.0%, 10g

1-(Difluoromethyl)-1H-pyrazole-4-carbaldehyde, 98%, 250mg

5-chloro-2-[(2-chloro-6-fluorobenzyl)oxy]benzaldehyde, 95.0%, 5g

2-Ethyl-4,5,6,7-tetrahydro-2h-indazol-3-amine, 95+%, 500mg

Ammonium heptamolybdate tetrahydrate, min. 99%, extra pure, 100 g, plastic packaging.